ATEA PHARMACEUTICALS INC (AVIR) — institutional ownership
132 funds reported holding ATEA PHARMACEUTICALS INC in their latest 13F filings, worth $293M in total (CUSIP 04683R106).
Largest holders
- FMR LLC — $55.8M
- BlackRock, Inc. (BLK) — $40.5M
- BML Capital Management, LLC — $32.3M
- TANG CAPITAL MANAGEMENT LLC — $22.4M
- VANGUARD GROUP INC — $15.1M
- VANGUARD CAPITAL MANAGEMENT LLC — $13.8M
- Bain Capital Life Sciences Investors, LLC — $9.65M
- ACADIAN ASSET MANAGEMENT LLC — $9.46M
- GEODE CAPITAL MANAGEMENT, LLC — $9.11M
- STATE STREET CORP (STT, STT-PG) — $7.68M
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- Renaissance Technologies portfolio (Renaissance Technologies)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Izzy Englander portfolio (Millennium Management)
- Ken Griffin portfolio (Citadel Advisors)
Insider buying and selling at ATEA PHARMACEUTICALS INC
Who owns the most AVIR stock?
The largest institutional holders in the latest 13F filings are FMR LLC ($55.8M), BlackRock, Inc. (BLK) ($40.5M), BML Capital Management, LLC ($32.3M).
How many funds own AVIR?
132 funds reported holding it, worth $293M in total.